(Q54646694)
Statements
Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib. (English)
Siraj M Ali
R Kathy Alpaugh
Jamie K Buell
Philip J Stephens
Jian Qin Michael Yu
Hong Wu
Christine N Hiemstra
Vincent A Miller
Doron Lipson
Gary A Palmer
Jeffrey S Ross
Massimo Cristofanilli
27 September 2013
14
1
e14-6